Patents by Inventor Jonathan Sleemann

Jonathan Sleemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kinase inhibitors and the use thereof
    Patent number: 8324267
    Abstract: The present invention relates to protein kinase inhibitors and to the use thereof for the treatment of diseases induced by pathological signal transduction cascades.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: December 4, 2012
    Assignee: Forschungzentrum Karlsruhe GmbH
    Inventors: Vladimir Chirchin, Giannis Athanassios, Ralph Mazitschek, Jonathan Sleemann
  • Method for identifying metastatic tumor cells
    Publication number: 20040265804
    Abstract: The present invention relates to a method for identifying and treating metastasizing tumor cells and to a population of cDNA sequences of metastasis-specific genes for use as tumor markers for identifying human cells and/or tissues possessing metastasis potential and for the therapy of cancer diseases.
    Type: Application
    Filed: November 24, 2003
    Publication date: December 30, 2004
    Inventors: Oliver von Stein, Andrea Nestl, Martin Hofmann, Jonathan Sleemann, Peter Herrlich
  • Kinase inhibitors and the use thereof
    Publication number: 20040248965
    Abstract: The present invention relates to protein kinase inhibitors and to the use thereof for the treatment of diseases induced by pathological signal transduction cascades.
    Type: Application
    Filed: July 6, 2004
    Publication date: December 9, 2004
    Inventors: Vladimir Chirchin, Giannis Athanassios, Ralph Mazitschek, Jonathan Sleemann